A Study of CS231295 in Patients With Advanced Solid Tumors

Clinical trial NCT07612488 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07612488
Sponsor: ThalassaX Therapeutics United States Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advance Solid Tumors Advanced Malignant Solid Tumors

Start date: 2026-06-01
Primary completion: 2027-12-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.